A 3D view of Barth syndrome mitochondria
For several decades, electron microscopy has provided pivotal information to pathologists on a large array of disease states that are associated with characteristic abnormalities of intracellular structures. However, an inherent limitation of conventional transmission electron microscopy is that it shows a more or less random 2D projection image of the object in question. In this issue, Acehan et al 1 (p. 40) used electron microscope tomography to study the 3D structure of mitochondria in patients with Barth Syndrome. Barth Syndrome is an Xlinked multisystemic disease caused by a defect in the metabolism of the mitochondrial phospholipid cardiolipin. 2, 3 Abnormal mitochondria have been documented in Barth patients, but the exact nature of the alterations in membrane architecture has remained elusive. The authors made use of conventional electron microscopy for statistical analysis of structures and collected tomography data of several representative areas for a detailed comparison. They have confirmed earlier observations about variations of mitochondrial population and size distribution in Barth Syndrome lymphoblasts compared to wildtype cells. Their work also revealed general organization of the cristae within the mitochondria where wild-type cells have an evenly spaced parallel distribution and Barth Syndrome mitochondria have their cristae concentrated close to the periphery of the mitochondrial volume. (In addition, most of the lamellar cristae studied in lymphoblasts showed a slot-like connection to the mitochondrial outer membrane.)
The authors' findings using detailed 3D comparisons of cristae structures are noteworthy. They report a novel feature of Barth Syndrome mitochondrial cristae, wherein some regions the membranes are very close to each other, resulting in minimization or deletion of crucial inter membrane space. Another observation that can be attributed to the 3D nature of their study was the discovery of novel tubular structures that were found only in mitochondria from Barth Syndrome patients. These structures seem to be connected to the rest of the mitochondrial cristae network.
Electron microscope tomography has been evolving rapidly due to advances in hardware and computer programs in the last years. This methodology is sure to gain more popularity in pathology, where 3D models can take away much of the ambiguity of 2D electron micrograph images, and reveal details otherwise invisible or hard to confirm. This method has also the potential to combine results from other 3D methods and biochemical studies to give a comprehensive understanding of structures and events at the molecular level. 
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Imaging lactate: pyruvate ratios in tissues
The most celebrated scientific effort in the eyes of the public is that being given to understanding the macromolecular basis of human disease, namely, derangement in nucleic acids and proteins. An overlooked fact is that it is the small molecules of intermediary metabolism that provide the metabolic energy for sustenance of life, and the building blocks for macromolecules. In the first instance, the most central of all metabolic pathways is glycolysis and oxidative metabolism via the Krebs cycle. permitted identification of the L/P ratios in solid human tumors-information which is rarely available. As the redox state of tumor cells might be critical for the efficiency of irradiation and a number of chemotherapeutics, and since lactate and pyruvate are known to have radical scavenger functions, it is likely that a correlation exists between the L/P ratio and radiosensitivity of tumors. As this imaging technique provides both quantitative and structural information, this paper represents an important advance in being able to obtain metabolic maps that reveal tumor heterogeneity. This work is therefore highly significant for advancing research in tumor biology, as well as improving diagnosis and prognosis assessment of cancer in a reproducible, standardized manner. The study shows that the mTOR pathway is activated in the entire spectrum of PTLD subtypes regardless of their EBV genome expression status, thus providing a pathobiological evidence that the mTOR pathway is ubiquitously activated in PTLDs.
mTOR is a protein kinase that controls cell growth by regulating many cellular processes, including protein synthesis and autophagy. Accumulated evidence indicates that mTOR integrates input from multiple upstream pathways, including insulin, growth factors, nutrients, mitogens and energy. Of interest, the mTOR pathway is hyperactive in certain cancers, suggesting mTOR as an attractive target for cancer therapy. 2 The authors previously demonstrated that EBV-transformed B lymphocytes are sensitive to mTOR inhibitors. 3 Taken together with the present study, these indicate that mTOR inhibitors, such as rapamycin and its derivatives, may be effective in treatment and prevention of PTLDs. This is particularly interesting considering the fact that reduction or withdrawal of immunosuppression is the cornerstone of the current treatment of PTLDs, which accompanies the risk of allograft rejection. As mTOR inhibitors have potent immunosuppressive effects, they may potentially act in the setting of PTLD as dual-function drugs by suppressing growth of PTLD cells and, at the same time, preventing immune rejection of the transplanted organ.
